debate

October 31, 2017October 31, 2017

#MSParis2017 – T-cell vs. B-cell Debate More Meeting of Minds Than ‘Rumble in the Jungle’

News

News commentary One particular session on Day 2 of the four-day 7th Joint ECTRIMS-ACTRIMS Meeting — which drew 10,000 researchers, doctors, industry representatives, and patient advocates ... Read more

October 26, 2017October 27, 2017

#MSParis2017 – Researchers Disagree on Feasibility of Using Disease-modifying Therapies in RIS Patients

News

Radiologically isolated syndrome (RIS) is a rare and relatively recent condition in which people have multiple sclerosis (MS)-like brain and spinal cord lesions without showing disease ... Read more

September 16, 2016September 16, 2016

#ECTRIMS2016 – Researchers Disagree on Feasibility of MS Bone Marrow Transplants

News

On the second day of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) 2016 Congress Sept. 14-17 in London, researchers shared their views on ... Read more

September 15, 2016September 15, 2016

#ECTRIMS2016 – Escalation vs. Induction Treatment for Early MS Topic of Debate

News

Two renowned multiple sclerosis (MS) specialists shared their opposing views regarding the use of escalation or induction treatment for newly diagnosed MS patients. The debate was at the ... Read more

March 18, 2016March 18, 2016

#CONy16: Can Vitamin D Be Considered a Disease Modifier for Multiple Sclerosis?

News

Vitamin D is crucial for our general health and it is known that it modulates immune responses. While large studies have shown that supplemental vitamin D lowers ... Read more

Pin It on Pinterest